Juwon Yim

502 total citations
19 papers, 336 citations indexed

About

Juwon Yim is a scholar working on Infectious Diseases, Molecular Medicine and Pharmacology. According to data from OpenAlex, Juwon Yim has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Molecular Medicine and 7 papers in Pharmacology. Recurrent topics in Juwon Yim's work include Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Juwon Yim is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Resistance in Bacteria (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Juwon Yim collaborates with scholars based in United States, Brazil and Colombia. Juwon Yim's co-authors include Michael J. Rybak, Jordan R. Smith, George Sakoulas, Razieh Kebriaei, Benjamin J Epstein, Kyle Stamper, Jason G. Newland, Warren E. Rose, Joseph Pogliano and John P. McRoberts and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Juwon Yim

17 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juwon Yim United States 12 179 116 97 88 84 19 336
David P. Nicolau United States 13 190 1.1× 97 0.8× 149 1.5× 127 1.4× 157 1.9× 22 446
Yoko Takayama Japan 9 107 0.6× 128 1.1× 46 0.5× 49 0.6× 100 1.2× 42 348
Flaminia Olearo Germany 12 234 1.3× 96 0.8× 49 0.5× 83 0.9× 118 1.4× 32 407
Cristina García de la Mària Spain 10 262 1.5× 55 0.5× 74 0.8× 114 1.3× 215 2.6× 15 346
Ines Noll Germany 10 125 0.7× 117 1.0× 31 0.3× 92 1.0× 104 1.2× 24 333
Carlos Garcés Colombia 9 178 1.0× 61 0.5× 45 0.5× 75 0.9× 74 0.9× 18 317
C. García-de-la-Mària Spain 12 293 1.6× 55 0.5× 58 0.6× 127 1.4× 225 2.7× 17 370
Damiano Bragantini Italy 11 203 1.1× 199 1.7× 89 0.9× 35 0.4× 100 1.2× 19 443
Céline Féger France 13 286 1.6× 75 0.6× 61 0.6× 125 1.4× 142 1.7× 18 425
Lucina Fossati Italy 11 135 0.8× 67 0.6× 36 0.4× 63 0.7× 101 1.2× 13 307

Countries citing papers authored by Juwon Yim

Since Specialization
Citations

This map shows the geographic impact of Juwon Yim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juwon Yim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juwon Yim more than expected).

Fields of papers citing papers by Juwon Yim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juwon Yim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juwon Yim. The network helps show where Juwon Yim may publish in the future.

Co-authorship network of co-authors of Juwon Yim

This figure shows the co-authorship network connecting the top 25 collaborators of Juwon Yim. A scholar is included among the top collaborators of Juwon Yim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juwon Yim. Juwon Yim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Yim, Juwon, et al.. (2024). Enoxaparin treatment dosing for venous thromboembolism in pediatric patients with obesity. Pediatric Blood & Cancer. 71(9). e31033–e31033.
2.
Yim, Juwon, et al.. (2024). Enoxaparin thromboprophylaxis in hospitalized obese pediatric patients. Pediatric Blood & Cancer. 71(9). e30942–e30942.
3.
Abdul‐Mutakabbir, Jacinda C., Juwon Yim, Kyle Stamper, et al.. (2021). In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii. Antibiotics. 10(7). 880–880. 24 indexed citations
4.
Yim, Juwon, Razieh Kebriaei, Jordan R. Smith, et al.. (2020). Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model. Antimicrobial Agents and Chemotherapy. 64(5). 24 indexed citations
5.
Yim, Juwon, et al.. (2018). Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 91(4). 363–370. 14 indexed citations
6.
7.
Smith, Jordan R., Juwon Yim, Seth Rice, et al.. (2018). Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations. Antimicrobial Agents and Chemotherapy. 62(5). 15 indexed citations
8.
Aires, Caio Augusto Martins, Michael J. Rybak, Juwon Yim, et al.. (2017). Genomic characterization of an extensively drug-resistant KPC-2-producing Klebsiella pneumoniae ST855 (CC258) only susceptible to ceftazidime-avibactam isolated in Brazil. Diagnostic Microbiology and Infectious Disease. 89(4). 324–327. 6 indexed citations
9.
Yim, Juwon, Jordan R. Smith, & Michael J. Rybak. (2017). Role of Combination Antimicrobial Therapy for Vancomycin‐Resistant Enterococcus faecium Infections: Review of the Current Evidence. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 37(5). 579–592. 58 indexed citations
10.
Yim, Juwon, Jordan R. Smith, Seth Rice, et al.. (2017). Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs). Journal of Antimicrobial Chemotherapy. 72(8). 2290–2296. 17 indexed citations
11.
Werth, Brian J., Poochit Nonejuie, John P. McRoberts, et al.. (2016). Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 60(10). 5716–5723. 33 indexed citations
12.
Yim, Juwon, et al.. (2016). Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application. Infectious Diseases and Therapy. 6(1). 57–67. 17 indexed citations
13.
14.
Sakoulas, George, Joshua Olson, Juwon Yim, et al.. (2016). Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy. 60(11). 6609–6618. 33 indexed citations
15.
Yim, Juwon, et al.. (2016). β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 61(1). 10 indexed citations
16.
17.
Gomes, Marisa Zenaide Ribeiro, Polyana Silva Pereira, Caio Augusto Martins Aires, et al.. (2016). Clonal Pan or Extensively Drug-Resistant KPC-2-Producing ST437 Klebsiella pneumoniae Causing Untreatable Infections Evidenced by In Vitro Synergy Testing. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations
18.
Smith, Jordan R., et al.. (2016). Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci. Antimicrobial Agents and Chemotherapy. 60(4). 2352–2358. 23 indexed citations
19.
Yim, Juwon, et al.. (2010). Efficacy and Safety of Ticagrelor: A Reversible P2Y12 Receptor Antagonist. Annals of Pharmacotherapy. 44(3). 524–537. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David P. Nicolau Breakdown of academic impact, for papers by Yoko Takayama Breakdown of academic impact, for papers by Flaminia Olearo Breakdown of academic impact, for papers by Cristina García de la Mària Breakdown of academic impact, for papers by Ines Noll Breakdown of academic impact, for papers by Carlos Garcés Breakdown of academic impact, for papers by C. García-de-la-Mària Breakdown of academic impact, for papers by Damiano Bragantini Breakdown of academic impact, for papers by Céline Féger Breakdown of academic impact, for papers by Lucina Fossati
Rankless by CCL
2026